Optical News

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today reported results for the first quarter ended April 3, 2026. First Quarter 2026 Financial Overview Net sales of $93.5 million, up 119.6% Y/Y Net sales excluding China of $46.1 million, up 6.0% Y/Y Gross margin at 73.6% vs. 65.8% a year ago Net income of $5.2 million or $0.10 per diluted share, com...

NEW PROVIDENCE, N.J.--(BUSINESS WIRE)--PRISM Vision Group announced that it closed a transaction with Retina Macula Institute, through which RMI joins its network of affiliated practices....

DULUTH, Ga.--(BUSINESS WIRE)--National Vision, Inc. (NASDAQ: EYE), one of the largest optical retailers in the United States, today reported its first quarter 2026 results....

CARLSBAD, Calif.--(BUSINESS WIRE)--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing “off the shelf” allogeneic cell therapies for serious medical conditions, today reported its first quarter 2026 financial and operating results. The Company will host a conference call today at 4:30 p.m. Eastern Time to discuss these results and to provide a business update. “This quarter, we continued to build on our developmental and clinical acc...

SACRAMENTO, Calif.--(BUSINESS WIRE)--NeuroVision Imaging acquires Durin Life Sciences to build a platform for earlier neurodegenerative disease detection and care....

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, today announced that its management is scheduled to participate in the following upcoming investor conferences: Stifel Virtual Ophthalmology Forum on Tuesday, May 26, 2026, at 1:30 p.m. ET William Blair 46th Annual Growth Stock Conference on Tuesday, June 2, 2026, at...

PARIS--(BUSINESS WIRE)--Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and central nervous system disorders, today announced the publication of a Matching Adjusted Indirect Comparison (MAIC) of outcomes from the clinical trials of GS010/LUMEVOQ®, the Company’s gene therapy investigational product for the treatment of ND4-LHO...

BOCA RATON, Fla.--(BUSINESS WIRE)--Bruno Vision Care's FDA-cleared Deseyne® Extended Depth of Focus daily disposable contact lens for presbyopia wins 2026 MedTech Breakthrough Award....

LONDON--(BUSINESS WIRE)--Asset Value Investors Limited (“AVI”) today announced an update to its public campaign regarding Rohto Pharmaceutical Co., Ltd. (TSE: 4527, “Rohto”), as a follow-up to its ongoing campaign, “Awakening Rohto”, launched last year and aimed at enhancing the company’s corporate value. AVI has published a detailed presentation on a dedicated website (www.AwakeningRohto.com). Since initiating its investment in June 2024, AVI has sought to engage in constructive dialogue with...

SMITHFIELD, R.I.--(BUSINESS WIRE)--Foster Grant, one of the world’s leading over-the-counter eyewear brands, has partnered with Sharper Image, an iconic brand known for merging innovative designs into everyday use items, to create a range of feature-rich eyewear. Designed to solve modern problems for modern consumers, the collection features four new reading glasses with cutting-edge features and seamless tech integration. The new collection centers the innovation and functionality that has mad...